Two landmark trials, The Diabetes Control & Complications Trial (DCCT) [4] and the UK Prospective Diabetes Study [8], reported increased incidence of hypoglycaemia with intensive therapy. HbA1c levels within the normal range are associated with increased risk of hypoglycaemia.
Type 1 diabetics
In type 1 diabetics, insulin errors, missed meals and excessive exercise were important causes of hypoglycaemia [9].
Type 2 diabetics
In type 2 diabetics, advanced age and inadequate energy intake are the main risk factors for those patients on sulphonylureas [10].
Elderly patients
In elderly patients, the main risk factors for severe hypoglycaemia are: